Solorank.ai
Cached score snapshot
US.SOLV · Solventum
110分制 61/110；5D動能v2 20/50；排序分 81/160
Score breakdown
觀望
Score and price trend
Main score, 5D momentum v2, close price, and improving or exit-review turn signals are plotted from archived daily snapshots.
Move the mouse over the chart lines to inspect readings.
- Main score
- 5D momentum v2
- Candlestick
- Historical projection
- Score turn
- Setup grade
| Model | Median | P25/P75 | 歷史相似情境上漲比例 | Down5 | Actual / compare |
|---|---|---|---|---|---|
| Rolling DOE best | +1.52% | -2.55% / +3.54% | 62.5% | 10% | Actual -0.35% · vs median -1.87% · inside 25-75 band |
| 30D observation | +4.81% | -1.01% / +10.59% | 72.5% | 15% | Actual outcome pending · 1 / 30 bars observed |
| Historical projection 10D n=160 | +0.60% | -1.41% / +3.07% | 58.8% | 5.6% | Actual outcome pending · 1 / 10 bars observed |
歷史情境統計基於已存檔相似 setup；圖中投影中位線為統計中位數的線性插值展示，並非價格路徑預測或買賣建議。
2026-05-29 → 2026-10-05 · 148 archived points · 2 Improving turn signal · 7 Deteriorating signal
Summary
score_with_momentum_v2 = main score + 5D momentum v2
Ranking score
81
Display grade
觀望
Model version
cursor_18_27_news_v2_160
Main score
61/110 (觀望)
5D momentum v2
20/50 (中)
Score with momentum v2
81/160 (低排序)
Risk level
Elevated
Rolling setup rating
Setup quality, historical edge, and risk are combined into a rolling S/A/B/C/D/F grade for this snapshot date.
Score turn monitor
Has the score quality changed?
Run more market refreshes to build enough archived points for a turn check.
Signals
技術信號 23.5 · 資金流 14.8 · 5D動能v2 20
INSTITUTIONAL_DATA_OPTIONAL: Institutional ownership unavailable; neutral money-flow treatment used. FMP_INSTITUTIONAL_FAILED: FMP HTTP 402
Audit trace
Full calculation detail
Calculation detail · 8 sections
Market inputs
Bar count
60
ma20
86.878
ma50
81.2166
close
91.25
prevClose
89.57
avgVolume20
1334145
volumeRatio
0.86
changePercent
1.88
Metrics snapshot
close
91.25
volume
1144696
changePercent
1.88
110-point main rating
基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10
Main score
61/110
Main rating
觀望
5D momentum v2
20/50
Score with momentum v2
81/160
Formula
score_with_momentum_v2 = main_score + momentum_5d_v2_score
基本面 — 3.4/5 · 一般
Dimension score
3.4/5
Dimension grade
一般
Sub-items
pbPoints
0.4
pePoints
0.5
epsPoints
0
roePoints
0.75
debtPoints
0.4
marginPoints
0.4
turnoverUsdM
104.4535
volumePoints
0.5
revenuePoints
0
dividendPoints
0
marketCapPoints
0.4
資金流 — 14.8/20 · 良好
Dimension score
14.8/20
Dimension grade
良好
Sub-items
cmfPoints
2.4
mfiPoints
2.4
obvPoints
4
vwapPoints
4
institutional
score
2
details
source
optional-neutral
warning
code
INSTITUTIONAL_DATA_OPTIONAL
symbol
US.SOLV
message
Institutional ownership is unavailable; neutral 2/4 money-flow treatment used.
optional
true
holderCount
n/a
holderPoints
2
top10ShareRatio
n/a
concentrationPenalty
0
institutionPoints
2
市場環境 — 7/15 · 較差
Dimension score
7/15
Dimension grade
較差
Sub-items
vix
score
2.4
details
source
twelvedata+fred
vixClose
15.13
trend
score
1.8
details
qqq
ma20
710.3985
ma50
713.2256
name
QQQ
close
706.32
points
0.4
spy
ma20
763.546
ma50
752.2638
name
SPY
close
763.47
points
1.4
source
twelvedata+fred
atrPct
3.2012
atrPoints
2
cciPoints
0.8
vixPoints
2.4
marketTrendPoints
1.8
催化劑 — 2/20 · 較差
Dimension score
2/20
Dimension grade
較差
Sub-items
catalyst
score
2
details
source
finnhub_news_keyword_model
articleCount
8
catalystCount
0
catalystPoints
2
風險管理 — 6.3/10 · 一般
Dimension score
6.3/10
Dimension grade
一般
Sub-items
position
score
1.1
details
atrPct
3.2012
turnoverUsdM
104.4535
liquidityPoints
0.4
volatilityPoints
0.7
rrPoints
1.4
stopLevels
symbol
US.SOLV
rr_range
1:1.0-1:2.5
risk_profile
中等
stop_loss_price
85.4078
strength_details
ma_score
1.5
atr_score
1
rsi_score
2
macd_score
3
volume_score
1
market_adjustment
1
risk_reward_ratio
1.1
stop_loss_percent
6.4
take_profit_price
97.9101
target_multiplier
1.9
technical_strength
1.8
take_profit_percent
7.3
positionPoints
1.1
stopLossPoints
1.8
diversification
score
2
details
method
sector concentration proxy; no portfolio holdings used
sector
Health Care
concentratedSectorPenalty
0
riskRewardRatio
1.2
stopLossPercent
6.4024
diversificationPoints
2
技術信號 — 23.5/30 · 良好
Dimension score
23.5/30
Dimension grade
良好
Sub-items
bbPoints
3
adxPoints
3
sarPoints
2.4
vcpPoints
2.6
macdPoints
4
vcpPayload
vcp_pass
false
vcp_score
2.6
vcp_reason
波幅收縮(15.8%→8.8%)；站上MA50；升放量(近10日2日)；收盤突破20日高位；Ready=N；Confirm=Y
vcp_metrics
up_days
7
vol_ref
1181646.6667
down_days
2
vcp_ready
false
above_ma50
true
avg_vol_10
1102350
avg_vol_20
1329180
avg_vol_30
1181646.6667
range_pct_10
0.0875
range_pct_20
0.1231
range_pct_30
0.1584
up_expand_ok
true
lookback_used
59
near_20d_high
true
contraction_ok
true
down_shrink_ok
false
up_expand_days
2
breakout_20d_ok
true
vol_ratio_10_30
0.9329
dist_to_20d_high
-0.0139
down_shrink_days
1
breakout_level_20d
90
vcp_breakout_confirm
true
contraction_ratio_10_30
0.5526
vcp_name_en
Volatility Contraction Pattern
vcp_name_zh
波動收縮形態
vol_contraction
true
kdjAdxPoints
0.7
rsiKdjPoints
4
volumeWeight
2
maCrossPoints
1.6
shortRsiPoints
1
shortMacdPoints
0.4
volConfirmPoints
0
volumePointsTechnical
0.8
情緒分析 — 4/10 · 較差
Dimension score
4/10
Dimension grade
較差
Sub-items
sentiment
score
4
details
source
finnhub_news_keyword_model
articleCount
8
negativeHits
0
positiveHits
3
sentimentScoreRaw
0.9
sentimentData
raw
{"id":141237779,"url":"https://finnhub.io/api/news?id=e344598255c9673102ba1313d573d1c3a3aa83d0bc7043f35aeaa1663a617a7e","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SOLV","summary":"Solventum plans to spin off its $1.4B HIS business, sharpening its MedTech focus while giving HIS more flexibility to pursue growth.","category":"company","datetime":1786725300,"headline":"SOLV Plans Health Information Systems Business Spinoff to Drive Growth"}, {"id":141202736,"url":"https://finnhub.io/api/news?id=1de5109a4997c36359eb80845578eba6dc4ee9bf54b859017205fb7ca2c044eb","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SOLV","summary":"CEO Hanson discusses HIS separation strategy and $2.2B in quarterly sales growth.","category":"company","datetime":1786582968,"headline":"Solventum (SOLV) Q2 2026 Earnings Call Transcript"}, {"id":141183734,"url":"https://finnhub.io/api/news?id=68d85bdd6def338a40765b4f619a75c6032d416da0c8e5efae1da55b061f8099","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SOLV","summary":"Healthcare solutions provider Solventum (NYSE:SOLV) reported revenue ahead of Wall Street’s expectations in Q2 CY2026, with sales up 2.2% year on year to $2.21 billion. Its non-GAAP profit of $2.55 per share was 33.8% above analysts’ consensus estimates.","category":"company","datetime":1786441282,"headline":"SOLV Q2 Deep Dive: Portfolio Restructuring and ERP Transition Shape Outlook"}, {"id":141165627,"url":"https://finnhub.io/api/news?id=4c18f0b8f2ecf2208f890041dddb9fed5118c68863434e4a9fbf2fbd5cb2e082","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SOLV","summary":"Solventum’s analyst fair value estimate has been revised from US$82.15 to US$93.15, a shift of about 13% in the updated framework. This adjustment aligns with recent analyst commentary that points to Q2 results, the planned Health Information Systems separation, and views on the company’s MedTech focus as reasons to revisit price targets. Read on to see how these factors shape the evolving Solventum narrative and what to watch as new data comes in. Analyst Price Targets don't always capture...","category":"company","datetime":1786262983,"headline":"Solventum (SOLV) Stock Fair Value Rises After Q2 And HIS Separation Plans"}, {"id":141131716,"url":"https://finnhub.io/api/news?id=a57df246be907a38a314d3e376968bcbe773e8865d03a98f7958af8e0fa93f38","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SOLV","summary":"Solventum Corp (SOLV) beats Q2 expectations with 9.5% organic growth, announces HIS separation, and raises full-year guidance.","category":"company","datetime":1785992755,"headline":"Solventum Corp (SOLV) (Q2 2026) Earnings Call Highlights: Strong Growth and Strategic ..."}, {"id":141129406,"url":"https://finnhub.io/api/news?id=b620bf515142c918d81f4d3fe3d39e8ab913797fead9081cbc74705e35398c65","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SOLV","summary":"Solventum (SOLV) delivered earnings and revenue surprises of +33.51% and +2.03%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?","category":"company","datetime":1785967808,"headline":"Solventum (SOLV) Q2 Earnings and Revenues Top Estimates"}, {"id":141129407,"url":"https://finnhub.io/api/news?id=c93f0a20e4bd483d9187d72f1e9c4b97f7c93123e7927042ea1036750c30b105","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SOLV","summary":"The headline numbers for Solventum (SOLV) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.","category":"company","datetime":1785967203,"headline":"Solventum (SOLV) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates"}, {"id":141129408,"url":"https://finnhub.io/api/news?id=1c938c7ad57b9b581cbb2c48be8b9c2ee37fb3607ff3de332b3cbf19854cc86e","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SOLV","summary":"Healthcare solutions provider Solventum (NYSE:SOLV) reported Q2 CY2026 results topping the market’s revenue expectations, with sales up 2.2% year on year to $2.21 billion. Its non-GAAP profit of $2.55 per share was 33.8% above analysts’ consensus estimates.","category":"company","datetime":1785963999,"headline":"Solventum (NYSE:SOLV) Posts Better-Than-Expected Sales In Q2 CY2026"}
raw_source
{"id":141285779,"url":"https://finnhub.io/api/news?id=7c86e597ea1845610c6ae5afb3837269e13b54c7d0a294610c15eef5e61e207f","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SOLV","summary":"From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Shareholders who bet on the industry have been rewarded lately as healthcare stocks have returned 27.5% over the past six months, topping the S&P 500 by 16.2 percentage points.","category":"company","datetime":1787234355,"headline":"1 Healthcare Stock for Long-Term Investors and 2 Facing Challenges"}, {"id":141237779,"url":"https://finnhub.io/api/news?id=e344598255c9673102ba1313d573d1c3a3aa83d0bc7043f35aeaa1663a617a7e","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SOLV","summary":"Solventum plans to spin off its $1.4B HIS business, sharpening its MedTech focus while giving HIS more flexibility to pursue growth.","category":"company","datetime":1786725300,"headline":"SOLV Plans Health Information Systems Business Spinoff to Drive Growth"}, {"id":141285780,"url":"https://finnhub.io/api/news?id=df4d8645c8c1ace8ed0fec7b8feaced53c0a8272fd880f36310d785343122e1a","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SOLV","summary":"Solventum has underperformed the broader market, while analysts remain moderately optimistic about its future prospects.","category":"company","datetime":1786705667,"headline":"Are Wall Street Analysts Bullish on Solventum Stock?"}, {"id":141202736,"url":"https://finnhub.io/api/news?id=1de5109a4997c36359eb80845578eba6dc4ee9bf54b859017205fb7ca2c044eb","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SOLV","summary":"CEO Hanson discusses HIS separation strategy and $2.2B in quarterly sales growth.","category":"company","datetime":1786582968,"headline":"Solventum (SOLV) Q2 2026 Earnings Call Transcript"}, {"id":141197531,"url":"https://finnhub.io/api/news?id=0ad00594b320b2b62379bd020b3f4d60a6b2410c1cb6d0ad82ea849220b24214","image":"","source":"SeekingAlpha","related":"SOLV","summary":"","category":"company","datetime":1786564051,"headline":"Tracking Christopher Davis' Davis Selected Advisers 13F Portfolio: Q2 2026 Update"}, {"id":141183734,"url":"https://finnhub.io/api/news?id=68d85bdd6def338a40765b4f619a75c6032d416da0c8e5efae1da55b061f8099","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SOLV","summary":"Healthcare solutions provider Solventum (NYSE:SOLV) reported revenue ahead of Wall Street’s expectations in Q2 CY2026, with sales up 2.2% year on year to $2.21 billion. Its non-GAAP profit of $2.55 per share was 33.8% above analysts’ consensus estimates.","category":"company","datetime":1786441282,"headline":"SOLV Q2 Deep Dive: Portfolio Restructuring and ERP Transition Shape Outlook"}, {"id":141165627,"url":"https://finnhub.io/api/news?id=4c18f0b8f2ecf2208f890041dddb9fed5118c68863434e4a9fbf2fbd5cb2e082","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SOLV","summary":"Solventum’s analyst fair value estimate has been revised from US$82.15 to US$93.15, a shift of about 13% in the updated framework. This adjustment aligns with recent analyst commentary that points to Q2 results, the planned Health Information Systems separation, and views on the company’s MedTech focus as reasons to revisit price targets. Read on to see how these factors shape the evolving Solventum narrative and what to watch as new data comes in. Analyst Price Targets don't always capture...","category":"company","datetime":1786262983,"headline":"Solventum (SOLV) Stock Fair Value Rises After Q2 And HIS Separation Plans"}, {"id":141165223,"url":"https://finnhub.io/api/news?id=93eca12886e802999219a5a8489f912ff2aad29671ed276e05cc92c1dc62882d","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SOLV","summary":"Solventum (NYSE:SOLV) reported second-quarter results that exceeded its internal expectations, supported by broad-based segment performance, planned order activity ahead of an ERP cutover and a tariff refund benefit. The company also announced plans to separate its Health Information Systems, or HIS","category":"company","datetime":1786259037,"headline":"Solventum Q2 Earnings Call Highlights"}, {"id":141138338,"url":"https://finnhub.io/api/news?id=66be9094570456fc28b35eb99f3c6ef5f0fc41d34be1f1ed72e8a3ae5118c97d","image":"https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp","source":"ChartMill","related":"SOLV","summary":"Stay informed about the performance of the S&P500 index one hour before the close of the markets on Thursday. Uncover the top gainers and losers in today's session for valuable insights.","category":"company","datetime":1786043101,"headline":"Explore the top gainers and losers within the S&P500 index in today's session."}, {"id":141140627,"url":"https://finnhub.io/api/news?id=821a2ebea1801a2ec5b1d31db9ec33eb8b6e8f606927bd12df7b938a1445bd09","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SOLV","summary":"SOLV's Q2 earnings and revenues beat estimates as organic sales increase 9.5%, prompting higher 2026 guidance despite ERP timing benefits.","category":"company","datetime":1786038780,"headline":"Solventum Stock Up as Q2 Earnings & Revenues Beat Estimates"}, {"id":141138455,"url":"https://finnhub.io/api/news?id=cd2ea0994254f995f5728da18bd18ae97c339fdf1afcd315d54bb652f0c0a45f","image":"","source":"Benzinga","related":"SOLV","summary":"UBS analyst Kevin Caliendo maintains Solventum (NYSE:SOLV) with a Buy and raises the price target from $95 to $101.","category":"company","datetime":1786027965,"headline":"UBS Maintains Buy on Solventum, Raises Price Target to $101"}, {"id":141138457,"url":"https://finnhub.io/api/news?id=d99aedf3913de0c8c7ab6dd95319df5c6c673925a60bfcd35977af9e9fca7566","image":"","source":"Benzinga","related":"SOLV","summary":"Piper Sandler analyst Jason Bednar maintains Solventum (NYSE:SOLV) with a Overweight and raises the price target from $92 to $105.","category":"company","datetime":1786020387,"headline":"Piper Sandler Maintains Overweight on Solventum, Raises Price Target to $105"}, {"id":141158422,"url":"https://finnhub.io/api/news?id=35a880cc1b13972c3b655c0a1e0ac0ccc31098c39bf7217c0fdb8ec011deeef2","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SOLV","summary":"Moby summary of Solventum Corporation's Q2 2026 earnings call","category":"company","datetime":1786019400,"headline":"Solventum Corporation Q2 2026 Earnings Call Summary"}, {"id":141138458,"url":"https://finnhub.io/api/news?id=da8f44787e47c4c689b389e77197e7bdd1d344b6495da7e404238f731536b601","image":"","source":"Benzinga","related":"SOLV","summary":"Wedbush analyst Michael Piccolo maintains Solventum (NYSE:SOLV) with a Outperform and raises the price target from $94 to $101.","category":"company","datetime":1786016675,"headline":"Wedbush Maintains Outperform on Solventum, Raises Price Target to $101"}, {"id":141138459,"url":"https://finnhub.io/api/news?id=5b25ff46b87e42a1b94b37eada3e1ace3a6adc71adfb51d75f19a047ce426f3f","image":"","source":"Benzinga","related":"SOLV","summary":"Keybanc analyst Brett Fishbin maintains Solventum (NYSE:SOLV) with a Overweight and raises the price target from $93 to $102.","category":"company","datetime":1786012912,"headline":"Keybanc Maintains Overweight on Solventum, Raises Price Target to $102"}, {"id":141138460,"url":"https://finnhub.io/api/news?id=623d39deb358c6a8aac603c759b8d206adca10dd2cf645664dd04c090247537e","image":"","source":"Benzinga","related":"SOLV","summary":"Stifel analyst Rick Wise maintains Solventum (NYSE:SOLV) with a Buy and raises the price target from $90 to $100.","category":"company","datetime":1786011857,"headline":"Stifel Maintains Buy on Solventum, Raises Price Target to $100"}, {"id":141135743,"url":"https://finnhub.io/api/news?id=5af91292874d9542e291856e56340dae0e6cd9e3b0caf5e50b6a89f886dfedff","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SOLV","summary":"The software business needs “a different investment level” to quickly realize its potential, Solventum’s CEO said.","category":"company","datetime":1786010400,"headline":"Solventum plans software separation to become ‘true medtech company’"}, {"id":141138461,"url":"https://finnhub.io/api/news?id=0fc86e65619d0648913b889e875c352b66cf94ed6f04329d1391a672b9d540c2","image":"","source":"Benzinga","related":"SOLV","summary":"BTIG analyst Ryan Zimmerman maintains Solventum (NYSE:SOLV) with a Buy and raises the price target from $91 to $95.","category":"company","datetime":1785995355,"headline":"BTIG Maintains Buy on Solventum, Raises Price Target to $95"}, {"id":141131716,"url":"https://finnhub.io/api/news?id=a57df246be907a38a314d3e376968bcbe773e8865d03a98f7958af8e0fa93f38","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SOLV","summary":"Solventum Corp (SOLV) beats Q2 expectations with 9.5% organic growth, announces HIS separation, and raises full-year guidance.","category":"company","datetime":1785992755,"headline":"Solventum Corp (SOLV) (Q2 2026) Earnings Call Highlights: Strong Growth and Strategic ..."}, {"id":141129405,"url":"https://finnhub.io/api/news?id=812e993c12ec5f679eb6a7cc5149754ba76c0b38b74c6f34af4130a7764aecdc","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SOLV","summary":"Investing.com -- Solventum Corp (NYSE:SOLV) reported second quarter results that exceeded analyst expectations and raised its full-year guidance, driven by strong organic sales growth across all business segments.","category":"company","datetime":1785970143,"headline":"Solventum beats estimates, raises guidance on strong growth"}, {"id":141129406,"url":"https://finnhub.io/api/news?id=b620bf515142c918d81f4d3fe3d39e8ab913797fead9081cbc74705e35398c65","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SOLV","summary":"Solventum (SOLV) delivered earnings and revenue surprises of +33.51% and +2.03%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?","category":"company","datetime":1785967808,"headline":"Solventum (SOLV) Q2 Earnings and Revenues Top Estimates"}, {"id":141129407,"url":"https://finnhub.io/api/news?id=c93f0a20e4bd483d9187d72f1e9c4b97f7c93123e7927042ea1036750c30b105","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SOLV","summary":"The headline numbers for Solventum (SOLV) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.","category":"company","datetime":1785967203,"headline":"Solventum (SOLV) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates"}, {"id":141129408,"url":"https://finnhub.io/api/news?id=1c938c7ad57b9b581cbb2c48be8b9c2ee37fb3607ff3de332b3cbf19854cc86e","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SOLV","summary":"Healthcare solutions provider Solventum (NYSE:SOLV) reported Q2 CY2026 results topping the market’s revenue expectations, with sales up 2.2% year on year to $2.21 billion. Its non-GAAP profit of $2.55 per share was 33.8% above analysts’ consensus estimates.","category":"company","datetime":1785963999,"headline":"Solventum (NYSE:SOLV) Posts Better-Than-Expected Sales In Q2 CY2026"}, {"id":141126827,"url":"https://finnhub.io/api/news?id=0c31fe0b2d0caab81d508e5fdaea005a58287c2047d6405ce71ba4ef83761794","image":"https://www.chartmill.com/images/uploads/CM_Aftermarket_Movers_Small_free_e077945a19.webp","source":"ChartMill","related":"SOLV","summary":"As the regular session of the US market on Wednesday comes to an end, let's delve into the after-hours session and discover the top S&P500 gainers and losers shaping the post-market sentiment.","category":"company","datetime":1785963901,"headline":"Stay updated with the S&P500 stocks that are on the move in today's after-hours session."}, {"id":141129792,"url":"https://finnhub.io/api/news?id=3fe57ef48ffcab5f3321f3f0b79c7558282ad2541944a6f58cd946969f3b538e","image":"https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png","source":"SeekingAlpha","related":"SOLV","summary":"2026-08-05. The following slide deck was published by Solventum Corporation in conjunction with their 2026 Q2 earnings call.","category":"company","datetime":1785963765,"headline":"Solventum Corporation 2026 Q2 - Results - Earnings Call Presentation"}, {"id":141129798,"url":"https://finnhub.io/api/news?id=a6167a4079c8eee5709eecf50af08823d78fa4e35dca1b815945517c4c43e660","image":"https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png","source":"SeekingAlpha","related":"SOLV","summary":"Solventum Corporation (SOLV) Q2 2026 Earnings Call August 5, 2026 4:30 PM EDTCompany ParticipantsAmy Wakeham - Senior Vice President of Investor Relations...","category":"company","datetime":1785963605,"headline":"Solventum Corporation (SOLV) Q2 2026 Earnings Call Transcript"}, {"id":141127666,"url":"https://finnhub.io/api/news?id=43314c4ead1b9bc3e3675ba56b9cb909203d870604b076179850602fbd959519","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SOLV","summary":"Solventum (NYSE: SOLV) today reported financial results for the second quarter ended June 30, 2026.","category":"company","datetime":1785960300,"headline":"Solventum Reports Second Quarter 2026 Financial Results"}, {"id":141127665,"url":"https://finnhub.io/api/news?id=fa8e2f0cbef44ad001aa898b35d5362c7b6d31327083a849dfad5525d29e727d","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SOLV","summary":"Solventum (NYSE: SOLV) today announced its intention to pursue a separation of its Health Information Systems business as part of the company's ongoing portfolio optimization strategy. The company will evaluate a range of separation pathways with the objective of maximizing shareholder value that position both Solventum and Health Information Systems for long-term success.","category":"company","datetime":1785960300,"headline":"Solventum Announces Intent to Separate its Health Information Systems Business"}, {"id":141138462,"url":"https://finnhub.io/api/news?id=ecdfacbc8640c99a5ef41259f5b6e9d3b8abc163904c546ed1a8eda9ad9689d2","image":"","source":"Benzinga","related":"SOLV","summary":"Solventum (NYSE: SOLV) today announced its intention to pursue a separation of its Health Information Systems business as part of the company's ongoing portfolio optimization strategy. The company will evaluate a","category":"company","datetime":1785948810,"headline":"Solventum Plans To Separate Its Health Information Systems Operations As Part Of Its Portfolio Optimization Strategy"}, {"id":141138463,"url":"https://finnhub.io/api/news?id=e8ccacb5e5d6d8f6e68be1324b3780167547e999e53ec0a57edb9703d017efce","image":"","source":"Benzinga","related":"SOLV","summary":"Solventum (NYSE:SOLV) reported quarterly earnings of $2.55 per share which beat the analyst consensus estimate of $1.91 by 33.51 percent. This is a 50.89 percent increase over earnings of $1.69 per share from the same","category":"company","datetime":1785946781,"headline":"Solventum Q2 Adj. EPS $2.55 Beats $1.91 Estimate, Sales $2.209B Beat $2.156B Estimate"}, {"id":141138464,"url":"https://finnhub.io/api/news?id=cdf12920b469880013a240ae54f9d4df3a9153eb5148024f2a6ff1332f0f1058","image":"","source":"Benzinga","related":"SOLV","summary":"Solventum (NYSE:SOLV) raises FY2026 Adj EPS guidance from $6.60 to $7.10-$7.20 vs $6.55 analyst estimate..","category":"company","datetime":1785946596,"headline":"Solventum Raises FY2026 Adj EPS Guidance from $6.60 to $7.10-$7.20 vs $6.55 Est"}, {"id":141114965,"url":"https://finnhub.io/api/news?id=a76269cd0057c2594211e58ca0d57d39fd42fa56d0cd555210da965d1354395d","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SOLV","summary":"McKesson, Cencora, Solventum and PacBio head into earnings with resilient demand offset by tariffs, funding pressure and pricing challenges.","category":"company","datetime":1785870480,"headline":"What's in Store for These 4 Healthcare Companies This Earnings Season?"}, {"id":141101106,"url":"https://finnhub.io/api/news?id=5abe8d9ae172747fe7022fcdf4b95538561fe7641d2aa18259c89c9f3cac727a","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SOLV","summary":"SOLV's Q2 results are likely to benefit from segment strength, Acera gains and cost savings, offset by tariffs and ERP-related sales timing shifts.","category":"company","datetime":1785774960,"headline":"Solventum to Report Q2 Earnings: What's in Store for the Stock?"}, {"id":141093867,"url":"https://finnhub.io/api/news?id=f313d2251dc4aeb66a33544f649f0fbe55f30728f01035fcaef9d6a2fa471782","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SOLV","summary":"Solventum (NYSE:SOLV) has appointed Neil Zieselman as Senior Vice President, Controller, and Chief Accounting Officer. He will succeed current Controller and Chief Accounting Officer Mary Wilcox following her retirement. Zieselman brings experience from Surgery Partners Inc., Stryker Corporation, Covanta Holding Corporation, Cendant Corporation, and Avaya Inc., and is a licensed CPA. Solventum enters this leadership change with its stock at $85.44 and a value score of 5, which can help...","category":"company","datetime":1785679682,"headline":"Solventum (SOLV) Appoints Neil Zieselman As New Chief Accounting Officer"}, {"id":141081735,"url":"https://finnhub.io/api/news?id=ca7e43a601dbfa7de127c36de15b1543fa1cdfc5ba5ebd1947eaadf8732b74ef","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SOLV","summary":"Each stock in this article is trading near its 52-week high. These elevated prices usually indicate some degree of investor confidence, business improvements, or favorable market conditions.","category":"company","datetime":1785524397,"headline":"3 Hyped Up Stocks That Fall Short"}, {"id":141049828,"url":"https://finnhub.io/api/news?id=4d59d6a7e2ebb7fe2d614bd60f7172755659f23996655852da433dcc1b2eab87","image":"","source":"Fintel","related":"SOLV","summary":"","category":"company","datetime":1785294366,"headline":"UBS Upgrades Solventum (SOLV)"}, {"id":141046067,"url":"https://finnhub.io/api/news?id=28852786028f830f8c93415f5e5497f7948584b12d1d51d853db9c580c37e955","image":"https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp","source":"ChartMill","related":"SOLV","summary":"Get insights into the S&P500 index performance on Tuesday. Explore the top gainers and losers within the S&P500 index in today's session.","category":"company","datetime":1785265501,"headline":"Exploring the top movers within the S&P500 index during today's session."}, {"id":141046204,"url":"https://finnhub.io/api/news?id=5a718149fa4c5903fd1c72528101f79d2754208b7938f5b4c5677e17a8a376bc","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SOLV","summary":"Nelson Peltz just made a healthcare technology spinoff his largest institutional bet, and the combination of a dirt-cheap valuation, an activist legend, and a company still sorting out its own identity creates a setup worth understanding before the market catches on.","category":"company","datetime":1785264529,"headline":"Nelson Peltz and Trian Take a New Position: The Turnaround Thesis"}, {"id":141044608,"url":"https://finnhub.io/api/news?id=d914c07964c6e02bbb3d0f3dab99f42869b3f4d48013c90488f66bd1641dc6d2","image":"https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp","source":"ChartMill","related":"SOLV","summary":"Stay updated with the movement of S&P500 stocks in today's session. Discover which S&P500 stocks are making waves on Tuesday.","category":"company","datetime":1785256501,"headline":"Tuesday's session: top gainers and losers in the S&P500 index"}, {"id":141053803,"url":"https://finnhub.io/api/news?id=31c0e6032d9065ddb5d0498444448cb28b52262665595ddc28c7f9d17d5e33b4","image":"","source":"Benzinga","related":"SOLV","summary":"UBS analyst Kevin Caliendo upgrades Solventum (NYSE:SOLV) from Neutral to Buy and announces $95 price target.","category":"company","datetime":1785250260,"headline":"UBS Upgrades Solventum to Buy, Announces $95 Price Target"}, {"id":141043102,"url":"https://finnhub.io/api/news?id=4def2ebd595d4441db1c358c20ea98221169d771dcb6942e98c2c7ed2cec1c4c","image":"https://www.chartmill.com/images/uploads/CM_Gap_Stocks_Small_free_ad767b11cf.webp","source":"ChartMill","related":"SOLV","summary":"Curious about the S&P500 stocks that are gapping on Tuesday? Explore the gap up and gap down stocks in the S&P500 index during today's session.","category":"company","datetime":1785249301,"headline":"These S&P500 stocks are gapping in today's session"}
data_source
finnhub_news_keyword_model
article_count
8
negative_hits
0
positive_hits
3
recomputed_at_score
true
sentiment_score_raw
0.9
source_article_count
41
discarded_article_count
30
sentimentPoints
4
Dimension contribution
Dimension
Raw
Max
Norm %
Contrib
基本面
3.4
5/110
68%
3.4
資金流
14.8
20/110
74%
14.8
市場環境
7
15/110
46.67%
7
催化劑
2
20/110
10%
2
風險管理
6.3
10/110
63%
6.3
技術信號
23.5
30/110
78.33%
23.5
情緒分析
4
10/110
40%
4
5D momentum v2 breakdown
Cursor_18.25 5D momentum v2 0-50
5D momentum v2
20/50
ret_5d
0.051
max_score
50
max_total
50
raw_total
20
vcp_bonus
0
vol_ratio
0.8612
ret_points
8
vol_points
0
range_ratio
0.7352
volat_points
0
day_range_pct
0.0236
model_version
cursor_18_27_news_v2_160
available_bars
30
breakout_points
8
partial_history
false
pullback_points
0
breakout_vol_bonus
0
first_breakout_20d
true
return_window_days
5
first_breakout_bonus
2
breakout_quality_points
2
Risk management
level
Elevated
reason
risk management score >= 5/10
position
score
1.1
details
atrPct
3.2012
turnoverUsdM
104.4535
liquidityPoints
0.4
volatilityPoints
0.7
rrPoints
1.4
stopLevels
symbol
US.SOLV
rr_range
1:1.0-1:2.5
risk_profile
中等
stop_loss_price
85.4078
strength_details
ma_score
1.5
atr_score
1
rsi_score
2
macd_score
3
volume_score
1
market_adjustment
1
risk_reward_ratio
1.1
stop_loss_percent
6.4
take_profit_price
97.9101
target_multiplier
1.9
technical_strength
1.8
take_profit_percent
7.3
positionPoints
1.1
stopLossPoints
1.8
diversification
score
2
details
method
sector concentration proxy; no portfolio holdings used
sector
Health Care
concentratedSectorPenalty
0
riskRewardRatio
1.2
stopLossPercent
6.4024
diversificationPoints
2
Calculation audit log
基本面分析總分: 3.4/5分 資金流分析總分: 14.8/20分 市場環境分析總分: 7/15分 催化劑分析: 2/20分 風險管理總分: 6.3/10分 技術信號分析總分: 23.5/30分 情緒分析: 4/10分 共振率(僅顯示不加分): 0%
Technical indicators
adx
value
92.86
atr
atr
2.9211
rule
ATR / current price; lower volatility scores higher
score
4
atr_pct
3.2
cci
rule
Cursor_18.24 CCI bands
level
超買或超賣風險
score
2
value
169.16
cmf
rule
Cursor_18.24 CMF bands
level
輕微流入
score
6
value
0.1866
kdj
d
77.18
j
107.56
k
87.31
rule
Cursor_18.24 K/D cross
score
4
signal
金叉
mfi
rule
Cursor_18.24 MFI bands
level
平衡
score
6
value
52.87
obv
rule
Cursor_18.24 recent_slope vs previous_slope
score
10
trend
強流入
value
7485996
recentSlope
695109.6
previousSlope
-326540
rsi
value
58.7
sar
rule
Cursor_18.24 Parabolic SAR
score
8
trend
上升
value
82.6324
position
SAR喺價下
distancePct
9.44
previousTrend
上升
ma50
value
81.2166
macd
macd
2.3233
trend
強烈看漲
signal
2.0848
histogram
0.2385
vwap
rule
Cursor_18.24 VWAP 20D consecutive close
score
10
value
86.6501
position
連續5日>VWAP
consecutiveAbove
11
volume
rule
Cursor_18.24 volume ratio
level
無力
ratio
0.86
score
4
avgVolume
1334145
currentVolume
1144696
derived
ma20
86.878
ma50
81.2166
prevClose
89.57
avgVolume10
1076780
avgVolume20
1334145
changePercent
1.88
avgVolumeForScore
1334145
ma_cross
ma20
86.878
ma50
81.2166
rule
Cursor_18.24 MA20/MA50 cross
cross
多頭
score
4
prevMa20
86.339
prevMa50
80.976
spreadPct
6.97
isVolumeBreakout
false
bollinger
lower
82.7428
upper
91.0132
position
上半部
rsi_short
value
71.45
macd_short
macd
0
trend
中性
signal
0
histogram
0
volume_ratio
ratio
0.86
Raw calculation JSON
{
"risk": {
"level": "Elevated",
"reason": "risk management score >= 5/10",
"position": {
"score": 1.1,
"details": {
"atrPct": 3.2012054794520552,
"turnoverUsdM": 104.45351,
"liquidityPoints": 0.4,
"volatilityPoints": 0.7
}
},
"rrPoints": 1.4,
"stopLevels": {
"symbol": "US.SOLV",
"rr_range": "1:1.0-1:2.5",
"risk_profile": "中等",
"stop_loss_price": 85.4078,
"strength_details": {
"ma_score": 1.5,
"atr_score": 1,
"rsi_score": 2,
"macd_score": 3,
"volume_score": 1
},
"market_adjustment": 1,
"risk_reward_ratio": 1.1,
"stop_loss_percent": 6.4,
"take_profit_price": 97.9101,
"target_multiplier": 1.9,
"technical_strength": 1.8,
"take_profit_percent": 7.3
},
"positionPoints": 1.1,
"stopLossPoints": 1.8,
"diversification": {
"score": 2,
"details": {
"method": "sector concentration proxy; no portfolio holdings used",
"sector": "Health Care",
"concentratedSectorPenalty": 0
}
},
"riskRewardRatio": 1.2,
"stopLossPercent": 6.4024109589041105,
"diversificationPoints": 2
},
"total": {
"max": 160,
"result": 81,
"formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
"baseScore": 61,
"modelVersion": "cursor_18_27_news_v2_160",
"momentum5dScore": 20
},
"market": {
"ma20": 86.878,
"ma50": 81.2166,
"close": 91.25,
"prevClose": 89.57,
"avgVolume20": 1334145,
"volumeRatio": 0.86,
"changePercent": 1.88
},
"sources": {
"catalyst": "finnhub_news_keyword_model",
"sentiment": "finnhub_news_keyword_model",
"fundamentals": "fmp_stable",
"institutional": null,
"marketContext": "twelvedata+fred"
},
"barCount": 60,
"momentum": {
"max": 50,
"result": 20,
"details": {
"ret_5d": 0.05102510942179239,
"max_score": 50,
"max_total": 50,
"raw_total": 20,
"vcp_bonus": 0,
"vol_ratio": 0.8612046524925142,
"ret_points": 8,
"vol_points": 0,
"range_ratio": 0.7352352046654441,
"volat_points": 0,
"day_range_pct": 0.0235616438356165,
"model_version": "cursor_18_27_news_v2_160",
"available_bars": 30,
"breakout_points": 8,
"partial_history": false,
"pullback_points": 0,
"breakout_vol_bonus": 0,
"first_breakout_20d": true,
"return_window_days": 5,
"first_breakout_bonus": 2,
"breakout_quality_points": 2
},
"formula": "Cursor_18.25 5D momentum v2 0-50",
"modelVersion": "cursor_18_27_news_v2_160"
},
"scoreMax": 110,
"composite": {
"max": 160,
"result": 81,
"formula": "Cursor_18.25 ranking score v2 (score_with_momentum_v2)",
"weights": [
{
"raw": 3.4,
"label": "基本面",
"weight": "5/110",
"normalized": 68,
"contribution": 3.4
},
{
"raw": 14.8,
"label": "資金流",
"weight": "20/110",
"normalized": 74,
"contribution": 14.8
},
{
"raw": 7,
"label": "市場環境",
"weight": "15/110",
"normalized": 46.67,
"contribution": 7
},
{
"raw": 2,
"label": "催化劑",
"weight": "20/110",
"normalized": 10,
"contribution": 2
},
{
"raw": 6.3,
"label": "風險管理",
"weight": "10/110",
"normalized": 63,
"contribution": 6.3
},
{
"raw": 23.5,
"label": "技術信號",
"weight": "30/110",
"normalized": 78.33,
"contribution": 23.5
},
{
"raw": 4,
"label": "情緒分析",
"weight": "10/110",
"normalized": 40,
"contribution": 4
}
],
"modelVersion": "cursor_18_27_news_v2_160"
},
"momentumMax": 50,
"scoreStatus": "checked",
"standard110": {
"rating": "觀望",
"result": 61,
"details": [
"基本面分析總分: 3.4/5分",
"資金流分析總分: 14.8/20分",
"市場環境分析總分: 7/15分",
"催化劑分析: 2/20分",
"風險管理總分: 6.3/10分",
"技術信號分析總分: 23.5/30分",
"情緒分析: 4/10分",
"共振率(僅顯示不加分): 0%"
],
"formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
"dimensionScores": {
"催化劑": 2,
"基本面": 3.4,
"資金流": 14.8,
"市場環境": 7,
"情緒分析": 4,
"技術信號": 23.5,
"風險管理": 6.3
},
"dimensionDetails": {
"催化劑": {
"max": 20,
"grade": "較差",
"items": {
"catalyst": {
"score": 2,
"details": {
"source": "finnhub_news_keyword_model",
"articleCount": 8,
"catalystCount": 0
}
},
"catalystPoints": 2
}
},
"基本面": {
"max": 5,
"grade": "一般",
"items": {
"pbPoints": 0.4,
"pePoints": 0.5,
"epsPoints": 0,
"roePoints": 0.75,
"debtPoints": 0.4,
"marginPoints": 0.4,
"turnoverUsdM": 104.45351,
"volumePoints": 0.5,
"revenuePoints": 0,
"dividendPoints": 0,
"marketCapPoints": 0.4
},
"source": "fmp_stable"
},
"資金流": {
"max": 20,
"grade": "良好",
"items": {
"cmfPoints": 2.4,
"mfiPoints": 2.4,
"obvPoints": 4,
"vwapPoints": 4,
"institutional": {
"score": 2,
"details": {
"source": "optional-neutral",
"warning": {
"code": "INSTITUTIONAL_DATA_OPTIONAL",
"symbol": "US.SOLV",
"message": "Institutional ownership is unavailable; neutral 2/4 money-flow treatment used."
},
"optional": true,
"holderCount": null,
"holderPoints": 2,
"top10ShareRatio": null,
"concentrationPenalty": 0
}
},
"institutionPoints": 2
}
},
"市場環境": {
"max": 15,
"grade": "較差",
"items": {
"vix": {
"score": 2.4,
"details": {
"source": "twelvedata+fred",
"vixClose": 15.13
}
},
"trend": {
"score": 1.7999999999999998,
"details": {
"qqq": {
"ma20": 710.3985018500001,
"ma50": 713.2256020399999,
"name": "QQQ",
"close": 706.32001,
"points": 0.4
},
"spy": {
"ma20": 763.5459993000001,
"ma50": 752.2638036,
"name": "SPY",
"close": 763.46997,
"points": 1.4
},
"source": "twelvedata+fred"
}
},
"atrPct": 3.2012054794520552,
"atrPoints": 2,
"cciPoints": 0.8,
"vixPoints": 2.4,
"marketTrendPoints": 1.7999999999999998
}
},
"情緒分析": {
"max": 10,
"grade": "較差",
"items": {
"sentiment": {
"score": 4,
"details": {
"source": "finnhub_news_keyword_model",
"articleCount": 8,
"negativeHits": 0,
"positiveHits": 3,
"sentimentScoreRaw": 0.9
}
},
"sentimentData": {
"raw": [
{
"id": 141237779,
"url": "https://finnhub.io/api/news?id=e344598255c9673102ba1313d573d1c3a3aa83d0bc7043f35aeaa1663a617a7e",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "SOLV",
"summary": "Solventum plans to spin off its $1.4B HIS business, sharpening its MedTech focus while giving HIS more flexibility to pursue growth.",
"category": "company",
"datetime": 1786725300,
"headline": "SOLV Plans Health Information Systems Business Spinoff to Drive Growth"
},
{
"id": 141202736,
"url": "https://finnhub.io/api/news?id=1de5109a4997c36359eb80845578eba6dc4ee9bf54b859017205fb7ca2c044eb",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "SOLV",
"summary": "CEO Hanson discusses HIS separation strategy and $2.2B in quarterly sales growth.",
"category": "company",
"datetime": 1786582968,
"headline": "Solventum (SOLV) Q2 2026 Earnings Call Transcript"
},
{
"id": 141183734,
"url": "https://finnhub.io/api/news?id=68d85bdd6def338a40765b4f619a75c6032d416da0c8e5efae1da55b061f8099",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "SOLV",
"summary": "Healthcare solutions provider Solventum (NYSE:SOLV) reported revenue ahead of Wall Street’s expectations in Q2 CY2026, with sales up 2.2% year on year to $2.21 billion. Its non-GAAP profit of $2.55 per share was 33.8% above analysts’ consensus estimates.",
"category": "company",
"datetime": 1786441282,
"headline": "SOLV Q2 Deep Dive: Portfolio Restructuring and ERP Transition Shape Outlook"
},
{
"id": 141165627,
"url": "https://finnhub.io/api/news?id=4c18f0b8f2ecf2208f890041dddb9fed5118c68863434e4a9fbf2fbd5cb2e082",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "SOLV",
"summary": "Solventum’s analyst fair value estimate has been revised from US$82.15 to US$93.15, a shift of about 13% in the updated framework. This adjustment aligns with recent analyst commentary that points to Q2 results, the planned Health Information Systems separation, and views on the company’s MedTech focus as reasons to revisit price targets. Read on to see how these factors shape the evolving Solventum narrative and what to watch as new data comes in. Analyst Price Targets don't always capture...",
"category": "company",
"datetime": 1786262983,
"headline": "Solventum (SOLV) Stock Fair Value Rises After Q2 And HIS Separation Plans"
},
{
"id": 141131716,
"url": "https://finnhub.io/api/news?id=a57df246be907a38a314d3e376968bcbe773e8865d03a98f7958af8e0fa93f38",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "SOLV",
"summary": "Solventum Corp (SOLV) beats Q2 expectations with 9.5% organic growth, announces HIS separation, and raises full-year guidance.",
"category": "company",
"datetime": 1785992755,
"headline": "Solventum Corp (SOLV) (Q2 2026) Earnings Call Highlights: Strong Growth and Strategic ..."
},
{
"id": 141129406,
"url": "https://finnhub.io/api/news?id=b620bf515142c918d81f4d3fe3d39e8ab913797fead9081cbc74705e35398c65",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "SOLV",
"summary": "Solventum (SOLV) delivered earnings and revenue surprises of +33.51% and +2.03%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?",
"category": "company",
"datetime": 1785967808,
"headline": "Solventum (SOLV) Q2 Earnings and Revenues Top Estimates"
},
{
"id": 141129407,
"url": "https://finnhub.io/api/news?id=c93f0a20e4bd483d9187d72f1e9c4b97f7c93123e7927042ea1036750c30b105",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "SOLV",
"summary": "The headline numbers for Solventum (SOLV) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.",
"category": "company",
"datetime": 1785967203,
"headline": "Solventum (SOLV) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates"
},
{
"id": 141129408,
"url": "https://finnhub.io/api/news?id=1c938c7ad57b9b581cbb2c48be8b9c2ee37fb3607ff3de332b3cbf19854cc86e",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "SOLV",
"summary": "Healthcare solutions provider Solventum (NYSE:SOLV) reported Q2 CY2026 results topping the market’s revenue expectations, with sales up 2.2% year on year to $2.21 billion. Its non-GAAP profit of $2.55 per share was 33.8% above analysts’ consensus estimates.",
"category": "company",
"datetime": 1785963999,
"headline": "Solventum (NYSE:SOLV) Posts Better-Than-Expected Sales In Q2 CY2026"
}
],
"raw_source": [
{
"id": 141285779,
"url": "https://finnhub.io/api/news?id=7c86e597ea1845610c6ae5afb3837269e13b54c7d0a294610c15eef5e61e207f",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "SOLV",
"summary": "From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Shareholders who bet on the industry have been rewarded lately as healthcare stocks have returned 27.5% over the past six months, topping the S&P 500 by 16.2 percentage points.",
"category": "company",
"datetime": 1787234355,
"headline": "1 Healthcare Stock for Long-Term Investors and 2 Facing Challenges"
},
{
"id": 141237779,
"url": "https://finnhub.io/api/news?id=e344598255c9673102ba1313d573d1c3a3aa83d0bc7043f35aeaa1663a617a7e",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "SOLV",
"summary": "Solventum plans to spin off its $1.4B HIS business, sharpening its MedTech focus while giving HIS more flexibility to pursue growth.",
"category": "company",
"datetime": 1786725300,
"headline": "SOLV Plans Health Information Systems Business Spinoff to Drive Growth"
},
{
"id": 141285780,
"url": "https://finnhub.io/api/news?id=df4d8645c8c1ace8ed0fec7b8feaced53c0a8272fd880f36310d785343122e1a",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "SOLV",
"summary": "Solventum has underperformed the broader market, while analysts remain moderately optimistic about its future prospects.",
"category": "company",
"datetime": 1786705667,
"headline": "Are Wall Street Analysts Bullish on Solventum Stock?"
},
{
"id": 141202736,
"url": "https://finnhub.io/api/news?id=1de5109a4997c36359eb80845578eba6dc4ee9bf54b859017205fb7ca2c044eb",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "SOLV",
"summary": "CEO Hanson discusses HIS separation strategy and $2.2B in quarterly sales growth.",
"category": "company",
"datetime": 1786582968,
"headline": "Solventum (SOLV) Q2 2026 Earnings Call Transcript"
},
{
"id": 141197531,
"url": "https://finnhub.io/api/news?id=0ad00594b320b2b62379bd020b3f4d60a6b2410c1cb6d0ad82ea849220b24214",
"image": "",
"source": "SeekingAlpha",
"related": "SOLV",
"summary": "",
"category": "company",
"datetime": 1786564051,
"headline": "Tracking Christopher Davis' Davis Selected Advisers 13F Portfolio: Q2 2026 Update"
},
{
"id": 141183734,
"url": "https://finnhub.io/api/news?id=68d85bdd6def338a40765b4f619a75c6032d416da0c8e5efae1da55b061f8099",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "SOLV",
"summary": "Healthcare solutions provider Solventum (NYSE:SOLV) reported revenue ahead of Wall Street’s expectations in Q2 CY2026, with sales up 2.2% year on year to $2.21 billion. Its non-GAAP profit of $2.55 per share was 33.8% above analysts’ consensus estimates.",
"category": "company",
"datetime": 1786441282,
"headline": "SOLV Q2 Deep Dive: Portfolio Restructuring and ERP Transition Shape Outlook"
},
{
"id": 141165627,
"url": "https://finnhub.io/api/news?id=4c18f0b8f2ecf2208f890041dddb9fed5118c68863434e4a9fbf2fbd5cb2e082",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "SOLV",
"summary": "Solventum’s analyst fair value estimate has been revised from US$82.15 to US$93.15, a shift of about 13% in the updated framework. This adjustment aligns with recent analyst commentary that points to Q2 results, the planned Health Information Systems separation, and views on the company’s MedTech focus as reasons to revisit price targets. Read on to see how these factors shape the evolving Solventum narrative and what to watch as new data comes in. Analyst Price Targets don't always capture...",
"category": "company",
"datetime": 1786262983,
"headline": "Solventum (SOLV) Stock Fair Value Rises After Q2 And HIS Separation Plans"
},
{
"id": 141165223,
"url": "https://finnhub.io/api/news?id=93eca12886e802999219a5a8489f912ff2aad29671ed276e05cc92c1dc62882d",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "SOLV",
"summary": "Solventum (NYSE:SOLV) reported second-quarter results that exceeded its internal expectations, supported by broad-based segment performance, planned order activity ahead of an ERP cutover and a tariff refund benefit. The company also announced plans to separate its Health Information Systems, or HIS",
"category": "company",
"datetime": 1786259037,
"headline": "Solventum Q2 Earnings Call Highlights"
},
{
"id": 141138338,
"url": "https://finnhub.io/api/news?id=66be9094570456fc28b35eb99f3c6ef5f0fc41d34be1f1ed72e8a3ae5118c97d",
"image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
"source": "ChartMill",
"related": "SOLV",
"summary": "Stay informed about the performance of the S&P500 index one hour before the close of the markets on Thursday. Uncover the top gainers and losers in today's session for valuable insights.",
"category": "company",
"datetime": 1786043101,
"headline": "Explore the top gainers and losers within the S&P500 index in today's session."
},
{
"id": 141140627,
"url": "https://finnhub.io/api/news?id=821a2ebea1801a2ec5b1d31db9ec33eb8b6e8f606927bd12df7b938a1445bd09",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "SOLV",
"summary": "SOLV's Q2 earnings and revenues beat estimates as organic sales increase 9.5%, prompting higher 2026 guidance despite ERP timing benefits.",
"category": "company",
"datetime": 1786038780,
"headline": "Solventum Stock Up as Q2 Earnings & Revenues Beat Estimates"
},
{
"id": 141138455,
"url": "https://finnhub.io/api/news?id=cd2ea0994254f995f5728da18bd18ae97c339fdf1afcd315d54bb652f0c0a45f",
"image": "",
"source": "Benzinga",
"related": "SOLV",
"summary": "UBS analyst Kevin Caliendo maintains Solventum (NYSE:SOLV) with a Buy and raises the price target from $95 to $101.",
"category": "company",
"datetime": 1786027965,
"headline": "UBS Maintains Buy on Solventum, Raises Price Target to $101"
},
{
"id": 141138457,
"url": "https://finnhub.io/api/news?id=d99aedf3913de0c8c7ab6dd95319df5c6c673925a60bfcd35977af9e9fca7566",
"image": "",
"source": "Benzinga",
"related": "SOLV",
"summary": "Piper Sandler analyst Jason Bednar maintains Solventum (NYSE:SOLV) with a Overweight and raises the price target from $92 to $105.",
"category": "company",
"datetime": 1786020387,
"headline": "Piper Sandler Maintains Overweight on Solventum, Raises Price Target to $105"
},
{
"id": 141158422,
"url": "https://finnhub.io/api/news?id=35a880cc1b13972c3b655c0a1e0ac0ccc31098c39bf7217c0fdb8ec011deeef2",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "SOLV",
"summary": "Moby summary of Solventum Corporation's Q2 2026 earnings call",
"category": "company",
"datetime": 1786019400,
"headline": "Solventum Corporation Q2 2026 Earnings Call Summary"
},
{
"id": 141138458,
"url": "https://finnhub.io/api/news?id=da8f44787e47c4c689b389e77197e7bdd1d344b6495da7e404238f731536b601",
"image": "",
"source": "Benzinga",
"related": "SOLV",
"summary": "Wedbush analyst Michael Piccolo maintains Solventum (NYSE:SOLV) with a Outperform and raises the price target from $94 to $101.",
"category": "company",
"datetime": 1786016675,
"headline": "Wedbush Maintains Outperform on Solventum, Raises Price Target to $101"
},
{
"id": 141138459,
"url": "https://finnhub.io/api/news?id=5b25ff46b87e42a1b94b37eada3e1ace3a6adc71adfb51d75f19a047ce426f3f",
"image": "",
"source": "Benzinga",
"related": "SOLV",
"summary": "Keybanc analyst Brett Fishbin maintains Solventum (NYSE:SOLV) with a Overweight and raises the price target from $93 to $102.",
"category": "company",
"datetime": 1786012912,
"headline": "Keybanc Maintains Overweight on Solventum, Raises Price Target to $102"
},
{
"id": 141138460,
"url": "https://finnhub.io/api/news?id=623d39deb358c6a8aac603c759b8d206adca10dd2cf645664dd04c090247537e",
"image": "",
"source": "Benzinga",
"related": "SOLV",
"summary": "Stifel analyst Rick Wise maintains Solventum (NYSE:SOLV) with a Buy and raises the price target from $90 to $100.",
"category": "company",
"datetime": 1786011857,
"headline": "Stifel Maintains Buy on Solventum, Raises Price Target to $100"
},
{
"id": 141135743,
"url": "https://finnhub.io/api/news?id=5af91292874d9542e291856e56340dae0e6cd9e3b0caf5e50b6a89f886dfedff",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "SOLV",
"summary": "The software business needs “a different investment level” to quickly realize its potential, Solventum’s CEO said.",
"category": "company",
"datetime": 1786010400,
"headline": "Solventum plans software separation to become ‘true medtech company’"
},
{
"id": 141138461,
"url": "https://finnhub.io/api/news?id=0fc86e65619d0648913b889e875c352b66cf94ed6f04329d1391a672b9d540c2",
"image": "",
"source": "Benzinga",
"related": "SOLV",
"summary": "BTIG analyst Ryan Zimmerman maintains Solventum (NYSE:SOLV) with a Buy and raises the price target from $91 to $95.",
"category": "company",
"datetime": 1785995355,
"headline": "BTIG Maintains Buy on Solventum, Raises Price Target to $95"
},
{
"id": 141131716,
"url": "https://finnhub.io/api/news?id=a57df246be907a38a314d3e376968bcbe773e8865d03a98f7958af8e0fa93f38",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "SOLV",
"summary": "Solventum Corp (SOLV) beats Q2 expectations with 9.5% organic growth, announces HIS separation, and raises full-year guidance.",
"category": "company",
"datetime": 1785992755,
"headline": "Solventum Corp (SOLV) (Q2 2026) Earnings Call Highlights: Strong Growth and Strategic ..."
},
{
"id": 141129405,
"url": "https://finnhub.io/api/news?id=812e993c12ec5f679eb6a7cc5149754ba76c0b38b74c6f34af4130a7764aecdc",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "SOLV",
"summary": "Investing.com -- Solventum Corp (NYSE:SOLV) reported second quarter results that exceeded analyst expectations and raised its full-year guidance, driven by strong organic sales growth across all business segments.",
"category": "company",
"datetime": 1785970143,
"headline": "Solventum beats estimates, raises guidance on strong growth"
},
{
"id": 141129406,
"url": "https://finnhub.io/api/news?id=b620bf515142c918d81f4d3fe3d39e8ab913797fead9081cbc74705e35398c65",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "SOLV",
"summary": "Solventum (SOLV) delivered earnings and revenue surprises of +33.51% and +2.03%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?",
"category": "company",
"datetime": 1785967808,
"headline": "Solventum (SOLV) Q2 Earnings and Revenues Top Estimates"
},
{
"id": 141129407,
"url": "https://finnhub.io/api/news?id=c93f0a20e4bd483d9187d72f1e9c4b97f7c93123e7927042ea1036750c30b105",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "SOLV",
"summary": "The headline numbers for Solventum (SOLV) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.",
"category": "company",
"datetime": 1785967203,
"headline": "Solventum (SOLV) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates"
},
{
"id": 141129408,
"url": "https://finnhub.io/api/news?id=1c938c7ad57b9b581cbb2c48be8b9c2ee37fb3607ff3de332b3cbf19854cc86e",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "SOLV",
"summary": "Healthcare solutions provider Solventum (NYSE:SOLV) reported Q2 CY2026 results topping the market’s revenue expectations, with sales up 2.2% year on year to $2.21 billion. Its non-GAAP profit of $2.55 per share was 33.8% above analysts’ consensus estimates.",
"category": "company",
"datetime": 1785963999,
"headline": "Solventum (NYSE:SOLV) Posts Better-Than-Expected Sales In Q2 CY2026"
},
{
"id": 141126827,
"url": "https://finnhub.io/api/news?id=0c31fe0b2d0caab81d508e5fdaea005a58287c2047d6405ce71ba4ef83761794",
"image": "https://www.chartmill.com/images/uploads/CM_Aftermarket_Movers_Small_free_e077945a19.webp",
"source": "ChartMill",
"related": "SOLV",
"summary": "As the regular session of the US market on Wednesday comes to an end, let's delve into the after-hours session and discover the top S&P500 gainers and losers shaping the post-market sentiment.",
"category": "company",
"datetime": 1785963901,
"headline": "Stay updated with the S&P500 stocks that are on the move in today's after-hours session."
},
{
"id": 141129792,
"url": "https://finnhub.io/api/news?id=3fe57ef48ffcab5f3321f3f0b79c7558282ad2541944a6f58cd946969f3b538e",
"image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
"source": "SeekingAlpha",
"related": "SOLV",
"summary": "2026-08-05. The following slide deck was published by Solventum Corporation in conjunction with their 2026 Q2 earnings call.",
"category": "company",
"datetime": 1785963765,
"headline": "Solventum Corporation 2026 Q2 - Results - Earnings Call Presentation"
},
{
"id": 141129798,
"url": "https://finnhub.io/api/news?id=a6167a4079c8eee5709eecf50af08823d78fa4e35dca1b815945517c4c43e660",
"image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
"source": "SeekingAlpha",
"related": "SOLV",
"summary": "Solventum Corporation (SOLV) Q2 2026 Earnings Call August 5, 2026 4:30 PM EDTCompany ParticipantsAmy Wakeham - Senior Vice President of Investor Relations...",
"category": "company",
"datetime": 1785963605,
"headline": "Solventum Corporation (SOLV) Q2 2026 Earnings Call Transcript"
},
{
"id": 141127666,
"url": "https://finnhub.io/api/news?id=43314c4ead1b9bc3e3675ba56b9cb909203d870604b076179850602fbd959519",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "SOLV",
"summary": "Solventum (NYSE: SOLV) today reported financial results for the second quarter ended June 30, 2026.",
"category": "company",
"datetime": 1785960300,
"headline": "Solventum Reports Second Quarter 2026 Financial Results"
},
{
"id": 141127665,
"url": "https://finnhub.io/api/news?id=fa8e2f0cbef44ad001aa898b35d5362c7b6d31327083a849dfad5525d29e727d",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "SOLV",
"summary": "Solventum (NYSE: SOLV) today announced its intention to pursue a separation of its Health Information Systems business as part of the company's ongoing portfolio optimization strategy. The company will evaluate a range of separation pathways with the objective of maximizing shareholder value that position both Solventum and Health Information Systems for long-term success.",
"category": "company",
"datetime": 1785960300,
"headline": "Solventum Announces Intent to Separate its Health Information Systems Business"
},
{
"id": 141138462,
"url": "https://finnhub.io/api/news?id=ecdfacbc8640c99a5ef41259f5b6e9d3b8abc163904c546ed1a8eda9ad9689d2",
"image": "",
"source": "Benzinga",
"related": "SOLV",
"summary": "Solventum (NYSE: SOLV) today announced its intention to pursue a separation of its Health Information Systems business as part of the company's ongoing portfolio optimization strategy. The company will evaluate a",
"category": "company",
"datetime": 1785948810,
"headline": "Solventum Plans To Separate Its Health Information Systems Operations As Part Of Its Portfolio Optimization Strategy"
},
{
"id": 141138463,
"url": "https://finnhub.io/api/news?id=e8ccacb5e5d6d8f6e68be1324b3780167547e999e53ec0a57edb9703d017efce",
"image": "",
"source": "Benzinga",
"related": "SOLV",
"summary": "Solventum (NYSE:SOLV) reported quarterly earnings of $2.55 per share which beat the analyst consensus estimate of $1.91 by 33.51 percent. This is a 50.89 percent increase over earnings of $1.69 per share from the same",
"category": "company",
"datetime": 1785946781,
"headline": "Solventum Q2 Adj. EPS $2.55 Beats $1.91 Estimate, Sales $2.209B Beat $2.156B Estimate"
},
{
"id": 141138464,
"url": "https://finnhub.io/api/news?id=cdf12920b469880013a240ae54f9d4df3a9153eb5148024f2a6ff1332f0f1058",
"image": "",
"source": "Benzinga",
"related": "SOLV",
"summary": "Solventum (NYSE:SOLV) raises FY2026 Adj EPS guidance from $6.60 to $7.10-$7.20 vs $6.55 analyst estimate..",
"category": "company",
"datetime": 1785946596,
"headline": "Solventum Raises FY2026 Adj EPS Guidance from $6.60 to $7.10-$7.20 vs $6.55 Est"
},
{
"id": 141114965,
"url": "https://finnhub.io/api/news?id=a76269cd0057c2594211e58ca0d57d39fd42fa56d0cd555210da965d1354395d",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "SOLV",
"summary": "McKesson, Cencora, Solventum and PacBio head into earnings with resilient demand offset by tariffs, funding pressure and pricing challenges.",
"category": "company",
"datetime": 1785870480,
"headline": "What's in Store for These 4 Healthcare Companies This Earnings Season?"
},
{
"id": 141101106,
"url": "https://finnhub.io/api/news?id=5abe8d9ae172747fe7022fcdf4b95538561fe7641d2aa18259c89c9f3cac727a",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "SOLV",
"summary": "SOLV's Q2 results are likely to benefit from segment strength, Acera gains and cost savings, offset by tariffs and ERP-related sales timing shifts.",
"category": "company",
"datetime": 1785774960,
"headline": "Solventum to Report Q2 Earnings: What's in Store for the Stock?"
},
{
"id": 141093867,
"url": "https://finnhub.io/api/news?id=f313d2251dc4aeb66a33544f649f0fbe55f30728f01035fcaef9d6a2fa471782",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "SOLV",
"summary": "Solventum (NYSE:SOLV) has appointed Neil Zieselman as Senior Vice President, Controller, and Chief Accounting Officer. He will succeed current Controller and Chief Accounting Officer Mary Wilcox following her retirement. Zieselman brings experience from Surgery Partners Inc., Stryker Corporation, Covanta Holding Corporation, Cendant Corporation, and Avaya Inc., and is a licensed CPA. Solventum enters this leadership change with its stock at $85.44 and a value score of 5, which can help...",
"category": "company",
"datetime": 1785679682,
"headline": "Solventum (SOLV) Appoints Neil Zieselman As New Chief Accounting Officer"
},
{
"id": 141081735,
"url": "https://finnhub.io/api/news?id=ca7e43a601dbfa7de127c36de15b1543fa1cdfc5ba5ebd1947eaadf8732b74ef",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "SOLV",
"summary": "Each stock in this article is trading near its 52-week high. These elevated prices usually indicate some degree of investor confidence, business improvements, or favorable market conditions.",
"category": "company",
"datetime": 1785524397,
"headline": "3 Hyped Up Stocks That Fall Short"
},
{
"id": 141049828,
"url": "https://finnhub.io/api/news?id=4d59d6a7e2ebb7fe2d614bd60f7172755659f23996655852da433dcc1b2eab87",
"image": "",
"source": "Fintel",
"related": "SOLV",
"summary": "",
"category": "company",
"datetime": 1785294366,
"headline": "UBS Upgrades Solventum (SOLV)"
},
{
"id": 141046067,
"url": "https://finnhub.io/api/news?id=28852786028f830f8c93415f5e5497f7948584b12d1d51d853db9c580c37e955",
"image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
"source": "ChartMill",
"related": "SOLV",
"summary": "Get insights into the S&P500 index performance on Tuesday. Explore the top gainers and losers within the S&P500 index in today's session.",
"category": "company",
"datetime": 1785265501,
"headline": "Exploring the top movers within the S&P500 index during today's session."
},
{
"id": 141046204,
"url": "https://finnhub.io/api/news?id=5a718149fa4c5903fd1c72528101f79d2754208b7938f5b4c5677e17a8a376bc",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "SOLV",
"summary": "Nelson Peltz just made a healthcare technology spinoff his largest institutional bet, and the combination of a dirt-cheap valuation, an activist legend, and a company still sorting out its own identity creates a setup worth understanding before the market catches on.",
"category": "company",
"datetime": 1785264529,
"headline": "Nelson Peltz and Trian Take a New Position: The Turnaround Thesis"
},
{
"id": 141044608,
"url": "https://finnhub.io/api/news?id=d914c07964c6e02bbb3d0f3dab99f42869b3f4d48013c90488f66bd1641dc6d2",
"image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
"source": "ChartMill",
"related": "SOLV",
"summary": "Stay updated with the movement of S&P500 stocks in today's session. Discover which S&P500 stocks are making waves on Tuesday.",
"category": "company",
"datetime": 1785256501,
"headline": "Tuesday's session: top gainers and losers in the S&P500 index"
},
{
"id": 141053803,
"url": "https://finnhub.io/api/news?id=31c0e6032d9065ddb5d0498444448cb28b52262665595ddc28c7f9d17d5e33b4",
"image": "",
"source": "Benzinga",
"related": "SOLV",
"summary": "UBS analyst Kevin Caliendo upgrades Solventum (NYSE:SOLV) from Neutral to Buy and announces $95 price target.",
"category": "company",
"datetime": 1785250260,
"headline": "UBS Upgrades Solventum to Buy, Announces $95 Price Target"
},
{
"id": 141043102,
"url": "https://finnhub.io/api/news?id=4def2ebd595d4441db1c358c20ea98221169d771dcb6942e98c2c7ed2cec1c4c",
"image": "https://www.chartmill.com/images/uploads/CM_Gap_Stocks_Small_free_ad767b11cf.webp",
"source": "ChartMill",
"related": "SOLV",
"summary": "Curious about the S&P500 stocks that are gapping on Tuesday? Explore the gap up and gap down stocks in the S&P500 index during today's session.",
"category": "company",
"datetime": 1785249301,
"headline": "These S&P500 stocks are gapping in today's session"
}
],
"data_source": "finnhub_news_keyword_model",
"article_count": 8,
"negative_hits": 0,
"positive_hits": 3,
"recomputed_at_score": true,
"sentiment_score_raw": 0.9,
"source_article_count": 41,
"discarded_article_count": 30
},
"sentimentPoints": 4
}
},
"技術信號": {
"max": 30,
"raw": 23.5,
"grade": "良好",
"items": {
"bbPoints": 3,
"adxPoints": 3,
"sarPoints": 2.4000000000000004,
"vcpPoints": 2.6,
"macdPoints": 4,
"vcpPayload": {
"vcp_pass": false,
"vcp_score": 2.6,
"vcp_reason": "波幅收縮(15.8%→8.8%)；站上MA50；升放量(近10日2日)；收盤突破20日高位；Ready=N；Confirm=Y",
"vcp_metrics": {
"up_days": 7,
"vol_ref": 1181646.6666666667,
"down_days": 2,
"vcp_ready": false,
"above_ma50": true,
"avg_vol_10": 1102350,
"avg_vol_20": 1329180,
"avg_vol_30": 1181646.6666666667,
"range_pct_10": 0.08750684931506848,
"range_pct_20": 0.12306849315068498,
"range_pct_30": 0.15835616438356168,
"up_expand_ok": true,
"lookback_used": 59,
"near_20d_high": true,
"contraction_ok": true,
"down_shrink_ok": false,
"up_expand_days": 2,
"breakout_20d_ok": true,
"vol_ratio_10_30": 0.9328930814061732,
"dist_to_20d_high": -0.013888888888888888,
"down_shrink_days": 1,
"breakout_level_20d": 90,
"vcp_breakout_confirm": true,
"contraction_ratio_10_30": 0.5525951557093424
},
"vcp_name_en": "Volatility Contraction Pattern",
"vcp_name_zh": "波動收縮形態",
"vol_contraction": true
},
"kdjAdxPoints": 0.7,
"rsiKdjPoints": 4,
"volumeWeight": 2,
"maCrossPoints": 1.6,
"shortRsiPoints": 1,
"shortMacdPoints": 0.4,
"volConfirmPoints": 0,
"volumePointsTechnical": 0.8
}
},
"風險管理": {
"max": 10,
"grade": "一般",
"items": {
"position": {
"score": 1.1,
"details": {
"atrPct": 3.2012054794520552,
"turnoverUsdM": 104.45351,
"liquidityPoints": 0.4,
"volatilityPoints": 0.7
}
},
"rrPoints": 1.4,
"stopLevels": {
"symbol": "US.SOLV",
"rr_range": "1:1.0-1:2.5",
"risk_profile": "中等",
"stop_loss_price": 85.4078,
"strength_details": {
"ma_score": 1.5,
"atr_score": 1,
"rsi_score": 2,
"macd_score": 3,
"volume_score": 1
},
"market_adjustment": 1,
"risk_reward_ratio": 1.1,
"stop_loss_percent": 6.4,
"take_profit_price": 97.9101,
"target_multiplier": 1.9,
"technical_strength": 1.8,
"take_profit_percent": 7.3
},
"positionPoints": 1.1,
"stopLossPoints": 1.8,
"diversification": {
"score": 2,
"details": {
"method": "sector concentration proxy; no portfolio holdings used",
"sector": "Health Care",
"concentratedSectorPenalty": 0
}
},
"riskRewardRatio": 1.2,
"stopLossPercent": 6.4024109589041105,
"diversificationPoints": 2
}
}
}
},
"modelVersion": "cursor_18_27_news_v2_160",
"providerErrors": [],
"rankingScoreMax": 160,
"dataCompleteness": {
"complete": true,
"missingFields": [],
"optionalInputs": [
"institutionalData"
],
"requiredInputs": [
"fundamentals",
"marketContext.VIX",
"marketContext.SPY",
"marketContext.QQQ",
"catalystData",
"sentimentData",
"ATR",
"sector"
],
"optionalInputWarnings": []
},
"technicalIndicators": {
"adx": 92.86,
"atr": {
"atr": 2.9211,
"rule": "ATR / current price; lower volatility scores higher",
"score": 4,
"atr_pct": 3.2
},
"cci": {
"rule": "Cursor_18.24 CCI bands",
"level": "超買或超賣風險",
"score": 2,
"value": 169.16
},
"cmf": {
"rule": "Cursor_18.24 CMF bands",
"level": "輕微流入",
"score": 6,
"value": 0.1866
},
"kdj": {
"d": 77.18,
"j": 107.56,
"k": 87.31,
"rule": "Cursor_18.24 K/D cross",
"score": 4,
"signal": "金叉"
},
"mfi": {
"rule": "Cursor_18.24 MFI bands",
"level": "平衡",
"score": 6,
"value": 52.87
},
"obv": {
"rule": "Cursor_18.24 recent_slope vs previous_slope",
"score": 10,
"trend": "強流入",
"value": 7485996,
"recentSlope": 695109.6,
"previousSlope": -326540
},
"rsi": 58.7,
"sar": {
"rule": "Cursor_18.24 Parabolic SAR",
"score": 8,
"trend": "上升",
"value": 82.6324,
"position": "SAR喺價下",
"distancePct": 9.44,
"previousTrend": "上升"
},
"ma50": 81.2166,
"macd": {
"macd": 2.3233143526195477,
"trend": "強烈看漲",
"signal": 2.084786442225691,
"histogram": 0.23852791039385668
},
"vwap": {
"rule": "Cursor_18.24 VWAP 20D consecutive close",
"score": 10,
"value": 86.6501,
"position": "連續5日>VWAP",
"consecutiveAbove": 11
},
"volume": {
"rule": "Cursor_18.24 volume ratio",
"level": "無力",
"ratio": 0.86,
"score": 4,
"avgVolume": 1334145,
"currentVolume": 1144696
},
"derived": {
"ma20": 86.878,
"ma50": 81.2166,
"prevClose": 89.57,
"avgVolume10": 1076780,
"avgVolume20": 1334145,
"changePercent": 1.88,
"avgVolumeForScore": 1334145
},
"ma_cross": {
"ma20": 86.878,
"ma50": 81.2166,
"rule": "Cursor_18.24 MA20/MA50 cross",
"cross": "多頭",
"score": 4,
"prevMa20": 86.339,
"prevMa50": 80.976,
"spreadPct": 6.97,
"isVolumeBreakout": false
},
"bollinger": {
"lower": 82.7428,
"upper": 91.0132,
"position": "上半部"
},
"rsi_short": 71.45,
"macd_short": {
"macd": 0,
"trend": "中性",
"signal": 0,
"histogram": 0
},
"volume_ratio": {
"ratio": 0.86
}
}
}
Raw metrics JSON
{
"close": 91.25,
"volume": 1144696,
"changePercent": 1.88
}
Scores are derived from cached daily market data using the Cursor_18.25 standard. Solorank.ai provides research support only and does not provide financial advice or buy/sell recommendations.